Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study

Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study

Objective Mutational analysis of BCR::ABL1 kinase domain (KD) is a crucial component of clinical decision algorithms for chronic myeloid leukemia (CML) patients with failure or warning responses to tyrosine kinase inhibitor (TKI) therapy. This study aimed to detect BCR::ABL1 KD mutations in CML pati...

Full description

Bibliographic Details
Published in:BMC RESEARCH NOTES
Main Authors: Abu Seman, Zahidah; Ahid, Fadly; Kamaluddin, Nor Rizan; Sahid, Ermi Neiza Mohd; Esa, Ezalia; Said, Siti Shahrum Muhamed; Azman, Norazlina; Mat, Wan Khairull Dhalila Wan; Abdullah, Julia; Ali, Nurul Aqilah; Khalid, Mohd Khairul Nizam Mohd; Yusoff, Yuslina Mat
Format: Article
Language:English
Published: SPRINGERNATURE 2024
Subjects:
Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics
Online Access:https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001205941900001

Similar Items

Similar Items